Union Budget 2026: Government’s sankalp to build a Healthy India and shape a Viksit Bharat
Union Budget 2026 signals a decisive pivot in India’s health policy to build the full stack required for an innovation-led, patient-centred health economy.
For more updates follow Grant Thornton Bharat on WhatsApp

India's medical devices market is one of the fastest growing in the world, driven by factors such as its increasing population, rising middle class, and governmental support.
Nevertheless, the market is characterised by intricate regulations, posing distinct challenges for stakeholders. When coupled with cost constraints and insufficient investment in research and development, the sector experiences adverse effects. By implementing a well-defined regulatory roadmap, placing a stronger emphasis on Production-Linked Incentive (PLI) schemes, and leveraging the benefits of the Make in India programme, the industry is poised for an upward trajectory.
We support the complete R&D value chain, right from ideation to research, development, and implementation.
Our dedicated healthcare team's technical expertise, commitment to understanding your concerns, and agile approach help you grow in the medical devices sector.
We offer tailored business advisory services to help our clients reach greater levels of success.
Union Budget 2026 signals a decisive pivot in India’s health policy to build the full stack required for an innovation-led, patient-centred health economy.
Explore Grant Thornton Bharat analysis of Union Budget 2024 impact on medical devices Industry, including key regulatory changes and potential challenges.

We help pharmaceutical and medical device companies comply with the Uniform Code for Pharmaceutical Marketing Practice.